The utility of the mood disorders questionnaire as a screening tool in a methadone maintenance treatment program

International Journal of Psychiatry in Clinical Practice

Volumn 14, Issue 2, 2010, Pages 150-153

  Villagonzalo, Kristi Ann ^a,b   Dodd, Seetal ^a,b   Ng, Felicity ^a,b   Mihaly, Stephen ^b   Langbein, Amy ^b   Berk, Michael ^a,b,c,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Mental Health and Drug and Alcohol Services   (Australia)

^c ORYGEN RESEARCH CENTRE   (Australia)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Bipolar disorder; Methadone maintenance; Mood disorder questionnaire; Screening tool; Substance abuse

Indexed keywords

AMPHETAMINE; BENZODIAZEPINE DERIVATIVE; CANNABIS; METHADONE; OPIATE;

ADULT; ARTICLE; BIPOLAR DISORDER; BIPOLAR MANIA; CANNABIS ADDICTION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG DEPENDENCE; FALSE POSITIVE RESULT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MOOD DISORDERS QUESTIONNAIRE; OPIATE ADDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING TEST;

EID: 77953202115     PISSN: 13651501     EISSN: 14711788     Source Type: Journal    
DOI: 10.3109/13651501003686828     Document Type: Article

References (12)

1. Cleary M, Hunt GE, Malins G, Matheson S, Escott P. Drug and alcohol education for consumer workers and caregivers: a pilot project assessing attitudes toward persons with mental illness and problematic substance use. Arch Psychiatr Nurs 2009;23(2):104-10.
2. Drake RE, Xie H, McHugo GJ, Shumway M. Three-year outcomes of long-term patients with co-occurring bipolar and substance use disorders. Biol Psychiatry 2004;56(10): 749-56.
3. Maremmani I, Perugi G, Pacini M, Akiskal HS. Toward a unitary perspective on the bipolar spectrum and substance abuse: opiate addiction as a paradigm. J Affect Disord 2006;93(1-3):1-12.
4. Milby JB, Sims MK, Khuder S, Schumacher JE, Huggins N, McLellan AT, et al. Psychiatric comorbidity: prevalence in methadone maintenance treatment. Am J Drug Alcohol Abuse 1996;22(1):95-107.
5. Maremmani I, Zolesi O, Aglietti M, Marini G, Tagliamonte A, Shinderman M, et al. Methadone dose and retention during treatment of heroin addicts with Axis I psychiatric comorbidity. J Addict Dis 2000;19(2):29-41.
6. Quello SB, Brady KT, Sonne SC. Mood disorders and substance use disorder: a complex comorbidity. Sci Pract Perspect 2005;3(1):13-21.
7. Teesson M, Havard A, Fairbairn S, Ross J, Lynskey M, Darke S. Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking. Drug Alcohol Depend 2005;78(3):309-15. (Pubitemid 40694053)
8. Brienza RS, Stein MD, Chen M, Gogineni A, Sobota M, Maksad J, et al. Depression among needle exchange program and methadone maintenance clients. J Subst Abuse Treat 2000;18(4):331-7.
9. Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE Jr, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry 2000;157(11): 1873-5.
10. Hirschfeld RM. Screening for bipolar disorder. Am J Manag Care 2007;13(Suppl 7):S164-9.
11. Berk M, Dodd S. Bipolar II disorder: a review. Bipolar Disord 2005;7(1):11-21.
12. Kemp DE, Hirschfeld RM, Ganocy SJ, Elhaj O, Slembarski R, Bilali S, et al. Screening for bipolar disorder in a county jail at the time of criminal arrest. J Psychiatr Res 2008;42(9): 778-86.